Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Study of Cornea Condition Reveals Hidden Risk Factors

January 14, 2016 9:22 am | by University of Michigan | News | Comments

A large new study reveals previously unknown risk factors associated with an eye condition that causes serious progressive nearsightedness at a relatively young age. Read more...

TOPICS:

Cost Squeeze Conundrum: Pay Up or Move Along?

January 14, 2016 8:51 am | by Roger Humphrey, Executive Managing Director, JLL Life Sciences | Articles | Comments

‘Invest in the best’ sounds good in theory—but it’s becoming a costly challenge for biopharmaceutical companies expanding their R&D operations in the United States. Large, mid-sized and small companies are all facing a growing cost squeeze for labor and laboratories near leading centers for research and innovation, while efficiency continues to be a major operational driver. It’s a challenging combination. Read more...

TOPICS:

Pfizer, Allergan CEOs: Tie-Up Aims for Growth, not Cost Cuts

January 14, 2016 8:15 am | by Linda A. Johnson, AP Business Writer | News | Comments

The deal announced last November would move Pfizer's official headquarters for tax purposes from New York to Allergan's base in Ireland. Read more...

TOPICS:
Advertisement

A Billion in Pandemic Prevention is Worth a Trillion in Cure

January 14, 2016 8:00 am | by John Tozzi, Bloomberg Business | News | Comments

In October 2000, an Ebola outbreak was detected in Gulu, Uganda. Read more...

BI, Arena Pharmaceuticals to Collaborate on Advancing Schizophrenia Research

January 14, 2016 7:45 am | News | Comments

According to the World Health Organization, mental illness - together with substance abuse disorders - remains the leading cause of disability worldwide. Read more...

TOPICS:

Takeda, enGene Team Up on Finding Novel Therapeutics for Gastrointestinal Diseases

January 14, 2016 7:30 am | News | Comments

Takeda will have an option to exclusively license the global rights for the product candidates. Read more...

TOPICS:

Glioblastoma Treatment Market Will Expand Fivefold to $3.3B by 2024

January 14, 2016 7:15 am | by Maxime Bourgognon, PharmD, Oncology and Hematology Analyst, GlobalData | News | Comments

Adults with glioblastoma have some of the highest levels of unmet need of any cancer patients. Read more...

TOPICS:

U.K. Health Officials: Any Amount of Alcohol Increases Cancer Risk

January 14, 2016 7:00 am | by Seth Augenstein, Digital Reporter | News | Comments

A new set of alcohol guidelines issued by health officials in the United Kingdom takes a hard stance. Read more...

TOPICS:
Advertisement

Researchers Further Illuminate Pathway for Treatment of Cystic Fibrosis

January 13, 2016 11:09 am | by University of North Carolina at Chapel Hill | News | Comments

It is well established that people with cystic fibrosis (CF) have two faulty copies of the CFTR gene, but debate continues on the question of whether certain symptoms of the airway disease are caused by the mutation or if the genetic defect precedes, but does not directly lead to some of the worst symptoms patients face. Read more...

TOPICS:

Probuphine Gets Advisory Committee Thumbs-Up

January 13, 2016 9:33 am | by Kristina Fiore, MedPage Today | News | Comments

An FDA advisory committee has voted 12 to 5 to recommend approval of a buprenorphine implant (Probuphine) to treat patients who are already stable on low doses of the sublingual version of the drug. Read more...

TOPICS:

Experimental Immunotherapy Zaps Two Most Lethal Ebola Virus Strains

January 13, 2016 9:17 am | by Albert Einstein College of Medicine | News | Comments

Researchers at Albert Einstein College of Medicine and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have engineered the first antibodies that can potently neutralize the two deadliest strains of the virus that causes Ebola hemorrhagic fever. Read more...

Senate Panel Approves Dr. Robert Califf as FDA Commisioner

January 13, 2016 9:05 am | by Mary Clare Jalonick, Associated Press | News | Comments

President Barack Obama's choice for commissioner of the Food and Drug Administration won easy approval from a Senate panel Tuesday, but two senators - a Republican and Democratic presidential candidate Bernie Sanders - threatened to block the nominee. Read more...

TOPICS:

Biden Reveals Details on Cancer Moonshot Project

January 13, 2016 9:00 am | by Ryan Bushey, Associate Editor | News | Comments

The Vice President started this project after he lost his son to brain cancer last year. Read more...

TOPICS:

Global Sjögren's Syndrome Treatment Market Will Double to $2.2B by 2024

January 13, 2016 8:21 am | by Haylyn Wong, Ph.D., Senior Cardiovascular and Metabolic Disorder Analyst, GlobalData | News | Comments

The Sjögren's syndrome treatment market will experience impressive growth over the next decade. Read more...

TOPICS:

Chromium Supplements Could Cause Cancer, Says Study

January 13, 2016 8:21 am | by Ryan Bushey, Associate Editor | Articles | Comments

It is ill-advised to take large quantities of these vitamins over long periods of time. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading